Status:
COMPLETED
Treatment of Patients With Acute Sinusitis
Lead Sponsor:
Bayer
Conditions:
Acute Bacterial Sinusitis
Eligibility:
All Genders
Brief Summary
For each patient, an initial visit and at least one follow-up visit at the end of treatment should be documented by the treating physician in the case report form.
Eligibility Criteria
Inclusion
- Any patient with a diagnosis of acute bacterial sinusitis treated with Avelox® - in accordance with the local production information.
Exclusion
- Those specified in the local product information - contraindications and precautions must be considered.
Key Trial Info
Start Date :
March 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
6777 Patients enrolled
Trial Details
Trial ID
NCT00930488
Start Date
March 1 2007
End Date
December 1 2008
Last Update
November 20 2012
Active Locations (19)
Enter a location and click search to find clinical trials sorted by distance.
1
Many Locations, Austria
2
Many Locations, Bahrain
3
Many Locations, China
4
Many Locations, Egypt